HomeFile

File

View Category
Aorta

The Real Impact of Peripheral Artery Disease in TAVR

Courtesy of Dr. Carlos Fava. The real incidence of peripheral artery (PAD) disease in TAVR remains unclear. Different...
solaci -
Learn More
Structural heart disease

ESC 2019 | How Benign Is Moderate Aortic Stenosis?

Data from a great Australian registry of nearly 250,000 people with a 5-year follow-up, presented at the...
solaci -
Learn More
Coronary disease

Theoretical Advantages Translated into Worst Clinical Outcomes: Synergy vs. Xience

New data from a real-world registry soon to be published in J Am Coll Cardiol Intv suggest...
solaci -
Learn More
Chronic Ischemic cardiopathy

ESC 2019 | CLARIFY: Symptoms Predict Risk Only in Patients with Prior MI

The 5-year follow up of patients with chronic stable angina (or as the guidelines currently call it...
solaci -
Learn More
Other

ESC 2019 | EVOPACS: Evolocumab to Reduce Cholesterol in Acute Coronary Syndromes

Eight weeks of treatment with evolocumab added to a regimen of high-intensity statins in patients with acute...
solaci -
Learn More
Chronic Ischemic cardiopathy

ESC 2019 | Pure: Body Mass Index Shows Low Correlation with Cardiovascular Events

This population study has found all-cause mortality is lower the lower body mass index (BMI) is, but...
solaci -
Learn More
Other

ESC 2019 | HOPE 4: Overcoming Obstacles to Treat Risk Factors in Developing Countries

Exhaustive intervention carried out by healthcare non-medical healthcare professionals with the support of community members resulted in...
solaci -
Learn More
Chronic Ischemic cardiopathy

ESC 2019 | SYNTAXES: Ten-Year Outcomes!

The SYNTAXES (SYNTAX Extended Survival) was presented at ESC 2019 with somewhat unexpected results in favor of...
solaci -
Learn More